Profound Medical (PROF) Non-Current Deferred Tax Liability (2023)

Profound Medical (PROF) posted quarterly Non-Current Deferred Tax Liability of $59000.0 for Q4 2023.

Profound Medical (PROF) Non-Current Deferred Tax Liability (2023) Analysis & Trends

Profound Medical's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $59000.0 for Q4 2023.

In Q4 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $59000.0; the TTM figure through Dec 2023 stood at $59000.0 (changed N/A YoY), while the FY2023 annual figure was $59000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability for Q4 2023 stood at $59000.0.
The five-year high for Non-Current Deferred Tax Liability was $59000.0 in Q4 2023, with the low at $59000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Profound Medical	241.00 Mn	202.73 Mn	1.95 Mn

Download Data

Date	Value
Dec 31, 2023	59,000.00
Dec 31, 2023	59,000.00